Maria Novella Romanelli

20PUBLICATIONS
38CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 28, 2026
Targeting Protein Tyrosine Phosphatase 1B: Recent Advances in Natural, Synthetic, and Multitarget Inhibitors for Diabetes Therapy.

|Jul 04, 2026
Piperazine Derivatives Carrying an Imidazole Ring as Selective Modulators of Human Carbonic Anhydrase Isozymes.

|May 01, 2026
Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuropathic Pain in Mice.

|Jul 27, 2024
Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold.

Laura Braconi, Chiara Riganti, Astrid Parenti

|Jan 11, 2024
Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023.

Maria Novella Romanelli, Laura Braconi, Alessio Gabellini

|Jun 30, 2023
DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole fumarate), a Novel Derivative of Ibogamine, Inhibits α7 and α9α10 Nicotinic Acetylcholine Receptors by Different Allosteric Mechanisms.

Han-Shen Tae, Marcelo O Ortells, Bassel J Tekarli

Pageof 4

Frequent Collaborators

12 joint publications

Dina Manetti

11 joint publications

Elisabetta Teodori

10 joint publications

Claudiu T Supuran

9 joint publications

Gianluca Bartolucci